Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(17%)
Results Posted
200%(2 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_4
3
50%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(2)

Detailed Status

Terminated2
unknown2
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 43 (75.0%)

Trials by Status

terminated233%
recruiting117%
completed117%
unknown233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6